SUBLIVAC® Birch PROBE Study

Status Completed

Clinical Trial Summary

Objective of the study is to show, on an exploratory basis, that treatment with SUBLIVAC Birch is also effective compared to treatment with Staloral Birch by means of reduction in allergic symptoms during nasal provocation in subjects suffering from IgE mediated allergic complaints triggered by birch pollen.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Birch Pollen Allergy
Conjunctivitis
Rhinitis, Allergic, Seasonal
Seasonal Rhinitis and/or Rhinoconjunctivitis

Clinical Trial Details

NCT number	NCT00932607
Study type	Interventional
Source	HAL Allergy
Contact
Status	Completed
Phase	Phase 2
Start date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06037148` - Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants	Phase 1
Completed	`NCT04912076` - S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen	Phase 1
Recruiting	`NCT05346718` - Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis	N/A
Completed	`NCT01137357` - Probiotics for Reduction Of Markers In Subjects With Allergy	N/A
Active, not recruiting	`NCT05668390` - Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma	Phase 3
Not yet recruiting	`NCT02146300` - Effect of the Nasal Provocation on the Breathing Style	N/A
Completed	`NCT01449786` - Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy	Phase 2
Completed	`NCT03969849` - Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants	Phase 1
Completed	`NCT04435678` - Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens	N/A
Completed	`NCT01628484` - Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation	Phase 1
Completed	`NCT00266526` - Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV	Phase 2
Completed	`NCT02143583` - Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment	Phase 2
Completed	`NCT02074930` - Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure	N/A
Completed	`NCT04266028` - Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy	Phase 1
Completed	`NCT00309062` - Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis	Phase 3
Completed	`NCT01675791` - A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet	Phase 2